JP2000159790A5 - - Google Patents

Download PDF

Info

Publication number
JP2000159790A5
JP2000159790A5 JP1999331141A JP33114199A JP2000159790A5 JP 2000159790 A5 JP2000159790 A5 JP 2000159790A5 JP 1999331141 A JP1999331141 A JP 1999331141A JP 33114199 A JP33114199 A JP 33114199A JP 2000159790 A5 JP2000159790 A5 JP 2000159790A5
Authority
JP
Japan
Prior art keywords
antibiotic drug
compound
formula
pharmaceutically acceptable
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1999331141A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000159790A (ja
Filing date
Publication date
Priority claimed from FR9814782A external-priority patent/FR2786188B1/fr
Application filed filed Critical
Publication of JP2000159790A publication Critical patent/JP2000159790A/ja
Publication of JP2000159790A5 publication Critical patent/JP2000159790A5/ja
Pending legal-status Critical Current

Links

JP11331141A 1998-11-24 1999-11-22 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用 Pending JP2000159790A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9814782 1998-11-24
FR9814782A FR2786188B1 (fr) 1998-11-24 1998-11-24 Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Publications (2)

Publication Number Publication Date
JP2000159790A JP2000159790A (ja) 2000-06-13
JP2000159790A5 true JP2000159790A5 (enExample) 2006-12-07

Family

ID=9533122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11331141A Pending JP2000159790A (ja) 1998-11-24 1999-11-22 新規のエリスロマイシン誘導体、それらの製造方法及びそれらの薬剤としての使用

Country Status (24)

Country Link
US (2) US6440941B1 (enExample)
EP (1) EP1004592B1 (enExample)
JP (1) JP2000159790A (enExample)
KR (1) KR100587445B1 (enExample)
CN (1) CN1165546C (enExample)
AR (1) AR021388A1 (enExample)
AT (1) ATE245160T1 (enExample)
AU (1) AU772171B2 (enExample)
BR (1) BR9905735A (enExample)
CA (1) CA2290136C (enExample)
DE (1) DE69909577T2 (enExample)
DK (1) DK1004592T3 (enExample)
ES (1) ES2198867T3 (enExample)
FR (1) FR2786188B1 (enExample)
HU (1) HUP9904392A3 (enExample)
IL (1) IL133101A (enExample)
MX (1) MXPA99010813A (enExample)
NO (1) NO314729B1 (enExample)
PL (1) PL336736A1 (enExample)
PT (1) PT1004592E (enExample)
RU (1) RU2237672C2 (enExample)
TR (1) TR199902888A3 (enExample)
TW (1) TWI247747B (enExample)
ZA (1) ZA997176B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
CZ20012675A3 (cs) 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
BR0010938A (pt) 1999-05-24 2002-03-19 Pfizer Prod Inc Derivados da 13-metil eritromicina
ES2222966T3 (es) 2000-06-30 2005-02-16 Pfizer Products Inc. Macrolidos antibioticos.
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
FR2862647B1 (fr) 2003-11-25 2008-07-04 Aventis Pharma Sa Derives de pyrazolyle, procede de preparation et intermediaires de ce procede a titre de medicaments et de compositions pharmaceutiques les renfermant
JP2008508322A (ja) * 2004-07-28 2008-03-21 ランバクシー ラボラトリーズ リミテッド 抗菌剤としてのケトライド誘導体
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
US8552162B2 (en) * 2008-05-09 2013-10-08 Enanta Pharmaceuticals, Inc. Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
CN102245195B (zh) * 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
EP3009442B1 (en) 2010-03-22 2019-06-19 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
CA2799937A1 (en) 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) * 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
EP2630133A1 (de) 2010-10-22 2013-08-28 Bayer Intellectual Property GmbH Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4182895A (en) * 1976-12-20 1980-01-08 Sterling Drug Inc. 1-Amino-lower-alkyl-3,4-diphenyl-1H-pyrazoles
CA1098527A (en) * 1976-12-20 1981-03-31 Denis M. Bailey 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
JPH04234891A (ja) * 1990-03-05 1992-08-24 Fujisawa Pharmaceut Co Ltd 新規セフェム化合物およびその塩
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CN1259135A (zh) * 1997-06-11 2000-07-05 辉瑞产品公司 9-肟红霉素衍生物
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments

Similar Documents

Publication Publication Date Title
JP2000159790A5 (enExample)
JP2002511411A5 (enExample)
CA2386690A1 (en) Pharmaceutical tramadol salts
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
CA2382919A1 (en) Bicyclic imidazo-3-yl-amine derivatives
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
CA2326222A1 (en) Medicinal compositions
EP1659111A3 (en) Piperidine derivatives useful as ccr5 antagonists
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
TNSN04213A1 (en) High drug load tablet
EP1076055A4 (en) 1- (1-SUBST.-4-PIPERIDINYL) METHYL] -4-PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL MIXTURES AND INTERMEDIATES FOR THE PRODUCTION THEREOF
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
CA2336412A1 (en) Medicament for treatment of diabetes
SE0300908D0 (sv) Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
NO20013060D0 (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
CA2393757A1 (en) Cycloamine ccr5 receptor antagonists
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
EP1426360A4 (en) 2-PHENYL-3-HETEROARYLPROPIONIC ACID DERIVATIVE OR SALT THEREOF AND MEDICAMENTS CONTAINING THE SAME
CA2005980A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
EP1149832A4 (en) BENZAMIDE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM
CA2373962A1 (en) Immediate release medicinal compositions for oral use
WO2004048381A3 (en) Pyrazoloazepine compounds as pharmaceutical agents
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
DE69635775D1 (de) Medikament gegen pulmonale herzprobleme